Comparative Effectiveness of Mindfulness-Based Stress Reduction and Pharmacotherapy for Anxiety

Brief description of study

The purpose of this study is to compare the effectiveness of a mindfulness-based stress reduction (MBSR) group intervention compared to individual pharmacological intervention with low-dose escitalopram for the treatment of Generalized Anxiety Disorder, Panic Disorder, Social Anxiety Disorder, and Agoraphobia. Patients will be randomized into two eight-week treatments: MBSR or escitalopram.


Clinical Study Identifier: s18-00130
ClinicalTrials.gov Identifier: NCT03522844
Principal Investigator: Naomi M. Simon.


If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.